{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-001447","form_type":"8-K","ticker":"HBIO","cik":"0001123494","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2026-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.565509+00:00","generated_at":"2026-05-15T15:29:34.595061+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Harvard Bioscience amends CEO pay, appoints Frost as CFO with $375k base","bullets":["CEO John Duke gets base salary $515k; $100k cash bonus tied to credit facility refinancing.","CEO eligible for annual cash incentive up to 80% of base; target 75k RSUs post 1:10 reverse split.","CFO Mark Frost appointed effective March 6, 2026; salary $375k, annual cash incentive up to 60%.","Frost's target equity grant for 2026 is 30k RSUs post reverse split; agreements run through 2027.","Reverse stock split (1:10) takes effect March 13, 2026 as previously announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-001447","json":"https://secwatch.observer/filing/0001171843-26-001447.json","markdown":"https://secwatch.observer/filing/0001171843-26-001447.md","text":"https://secwatch.observer/filing/0001171843-26-001447.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326001447/0001171843-26-001447-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326001447/f8k_031026.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T15:29:34.595061+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}